TribLIVE

| News


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Treatment devised at Pitt could ease breathing woes

Sunday, March 31, 2013, 12:59 p.m.
 

A new molecule developed in Pittsburgh eases inflammation in rodent cases of pneumonia, a discovery that could help people with respiratory infections, according to research released on Sunday.

A refined version of the treatment eventually “might be useful in improving outcomes” for pneumonia patients, said Dr. Rama Mallampalli, a vice chairman for research in the University of Pittsburgh School of Medicine. He said clinical trials for people could materialize within a few years.

The Department of Veterans Affairs and the National Institutes of Health supported the research, conducted during the past three to four years at Pitt and the VA Pittsburgh Healthcare System.

Mallampalli is the senior author in a paper about the findings, published this week in the journal Nature Immunology.

He said researchers are looking at whether other treatments could have a similar effect on ailments such as arthritis, asthma and colitis, all of which involve inflammation.

 

 

 
 


Show commenting policy

Most-Read Allegheny

  1. Allegheny County health officials call on retirement homes to stay vigilant on Legionella prevention
  2. Report linking field surface to cancer elicits Mt. Lebanon protest
  3. Pittsburgh’s Veterans Day parade moves to Saturday
  4. Unexpected work delays Allegheny County Health Department’s move into former morgue
  5. Move-in begins at new homes on site of Hill District housing project
  6. Newsmaker: Robert E. Neely
  7. Contempt citation sought by state against Highmark for alleged violation of deal with UPMC
  8. Canadians more fearful, aware after ‘very rare’ attack in Ottawa
  9. Parkway West off-ramps at Carnegie to close beginning Friday night
  10. VA promotion for administrator stuns legislator
  11. Prosecutors say cyanide-death defendant Ferrante tested toxin on mice to gauge effect on human
Subscribe today! Click here for our subscription offers.